Streetbeat News

Price Targets

NVO

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Novo Nordisk (NVO) and maintained a price target of $160. This reaffirmation of confidence in NVO's stock suggests a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:33 pm

MRK

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:28 pm

CAG

Wells Fargo analyst Chris Carey has maintained an Equal-Weight rating on Conagra Brands (CAG) and increased the price target from $30 to $32.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:27 pm

LLY

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly and Co (LLY) and maintained a price target of $815.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:26 pm

LW

Wells Fargo analyst Marc Torrente maintains an Overweight rating on Lamb Weston Holdings (LW) but lowers the price target from $128 to $98.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:21 pm

RARE

Cantor Fitzgerald analyst Kristen Kluska reiterated an Overweight rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) and maintained a $107 price target.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:21 pm

CMCSA

Wells Fargo analyst Steven Cahall has maintained an Equal-Weight rating on Comcast (NASDAQ:CMCSA) but has lowered the price target from $50 to $47.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:19 pm

CABA

Cantor Fitzgerald analyst Joshua Schimmer has reiterated an Overweight rating on Cabaletta Bio (NASDAQ:CABA), maintaining a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:19 pm

CHTR

Wells Fargo analyst Steven Cahall has maintained an Equal-Weight rating on Charter Communications (CHTR) and reduced the price target from $340 to $290.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:17 pm

LULU

Oppenheimer analyst Brian Nagel has reiterated an Outperform rating on Lululemon Athletica (NASDAQ:LULU), while lowering the price target from $540 to $445.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:17 pm